Ipamorelin $30.00 SKU: IP5 All sales are final
Higher starting BMI, younger age, absence of metabolic comorbidities, and aggressive lifestyle optimization (high protein, strength training, consistent dosing) can all push results beyond the mean
No blood pressure or resting heart rate
Weight loss is a health intervention, not a magic solution for lifes complexities
CICC maintains an "outperform" rating for JD Health with a target price of HK$41.2, while Morgan Stanley has lowered the target price from HK$43 to HK$40, with a rating of "in line with the overall market."
Improvement in obesity-related conditions may affect sleep patterns